Latest Versant Venture Management, LLC Stock Portfolio
Versant Venture Management, LLC Performance:
2025 Q3: 31.05%YTD: 14.96%2024: -32.1%
Performance for 2025 Q3 is 31.05%, and YTD is 14.96%, and 2024 is -32.1%.
About Versant Venture Management, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Versant Venture Management, LLC reported an equity portfolio of $212.5 Millions as of 30 Sep, 2025.
The top stock holdings of Versant Venture Management, LLC are , GLUE, AVTE. The fund has invested 58.2% of it's portfolio in LENZ THERAPEUTICS, INC. and 19.7% of portfolio in MONTE ROSA THERAPEUTICS, INC.
They significantly reduced their stock positions in CRISPR THERAPEUTICS AG (CRSP). Versant Venture Management, LLC opened new stock positions in LENZ THERAPEUTICS, INC..
The top stock holdings of Versant Venture Management, LLC are , GLUE, AVTE. The fund has invested 58.2% of it's portfolio in LENZ THERAPEUTICS, INC. and 19.7% of portfolio in MONTE ROSA THERAPEUTICS, INC.
They significantly reduced their stock positions in CRISPR THERAPEUTICS AG (CRSP). Versant Venture Management, LLC opened new stock positions in LENZ THERAPEUTICS, INC..
Versant Venture Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Versant Venture Management, LLC made a return of 31.05% in the last quarter. In trailing 12 months, it's portfolio return was 3.18%.
New Buys
| Ticker | $ Bought |
|---|---|
| lenz therapeutics, inc. | 123,758,000 |
New stocks bought by Versant Venture Management, LLC
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| crispr therapeutics ag | -70.15 |
Versant Venture Management, LLC reduced stake in above stock
Sold off
Sector Distribution
Versant Venture Management, LLC has about 65% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 65 |
| Healthcare | 35 |
Market Cap. Distribution
Versant Venture Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 65 |
| MICRO-CAP | 23 |
| NANO-CAP | 7.5 |
| MID-CAP | 4.5 |
Stocks belong to which Index?
About 25.9% of the stocks held by Versant Venture Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 74.1 |
| RUSSELL 2000 | 25.9 |
Versant Venture Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Versant Venture Management, LLC
Versant Venture Management, LLC has 9 stocks in it's portfolio. AVTE proved to be the most loss making stock for the portfolio. GLUE was the most profitable stock for Versant Venture Management, LLC last quarter.
Last Reported on: 10 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ADVM | adverum biotechnologies, inc. | 1.08 | 506,821 | 2,295,900 | unchanged | 0.00 | ||
| AVTE | jade biosciences, inc. | 6.20 | 1,525,820 | 13,167,800 | unchanged | 0.00 | ||
| CRSP | crispr therapeutics ag | 4.54 | 148,831 | 9,645,740 | reduced | -70.15 | ||
| GLUE | monte rosa therapeutics, inc. | 19.72 | 5,652,920 | 41,888,200 | unchanged | 0.00 | ||
| RPTX | repare therapeutics, inc. | 2.19 | 2,646,660 | 4,658,120 | unchanged | 0.00 | ||
| SKYE | skye bioscience, inc. | 3.71 | 2,007,700 | 7,890,280 | unchanged | 0.00 | ||
| TPST | tempest therapeutics, inc. | 1.30 | 269,772 | 2,773,260 | unchanged | 0.00 | ||
| lenz therapeutics, inc. | 58.25 | 2,656,890 | 123,758,000 | new | ||||
| contineum therapeutics, inc. | 3.00 | 542,628 | 6,375,880 | unchanged | 0.00 | |||